Koen Andries is a Belgian Janssen Pharmaceutica scientist and professor at the University of Antwerp. In 2005 he and his team published a discovery about a new di- Aryl- Quinoline-based drug ( R207910), now called bedaquiline, which promises a shorter and simpler treatment for drug resistant Tuberculosis (TB). ^[1]

Career

Andries graduated as a Veterinarian and obtained a PhD at the University of Ghent ( Ghent, Belgium) in 1975. He continued his career at the university until 1982, when he started working at Janssen Pharmaceutica in Beerse until 2004. In 2004 he continued his research at Tibotec in Mechelen.^{[ citation needed]}

Recognition

• 2014 winner of the European Inventor Award in the Industry category ^[2] awarded by the European Patent Office.

References

External links

• Koen Andries ( University of Antwerp)
• Koen Andries and his team ( European Patent Office)

This Belgian biographical article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e